The drugmaker Mylan NV said Monday it would offer a generic version of the EpiPen, the company's second move in a week to contain public outrage over perceived price gouging.
A powerful antibiotic combination that is marketed in India by US pharmaceutical giant Abbott Laboratories is among 344 drug combinations that have been banned by the Indian health authorities.
People who take aspirin regularly have a significantly lower risk of cancer, particularly involving the colon and gastrointestinal tract, according to US research published on Thursday.
A man who was left brain-dead after suffering serious side-effects during a drugs trial in France died on Sunday, according to the hospital which had been treating him.
